Duopharma Biotech Declares 1.0 Sen Interim Dividend for H1 FY2019
Kuala Lumpur, August 30, 2019 – Duopharma Biotech Berhad’s (formerly known as CCM Duopharma Biotech Berhad) (“Duopharma Biotech”) Board of Directors has recommended a single tier interim dividend of 1.0 sen per share based on paid up capital of 680,106,506 shares amounting to approximately RM6.80 million for the current financial period ended 30 June 2019.